7 A meta-analysis of outcomes data from completed cardiovascular outcome trials suggests that, apart from saxagliptin, DPP-4 inhibitors have a neutral effect on the risk of cardiovascular death, myocardial infarction, stroke and hospitalisation for heart failure
Highlights of the findings include: Stopping the semaglutide 3 to 5 days prior to surgery was identified as an independent risk factor for delayed emergence from anesthesia
2021Jun25;78(1):e1e2
Nevertheless, clinical trials or preclinical studies with head-to-head comparisons are not available to date in this regard
These could indicate an infection from a contaminated product and require immediate medical attention
Acta Diabetol 60(9):12571266 Lunati ME, Cimino V, Bernasconi D, Gandolfi A, Morpurgo PS, Tinari C et al (2024) Type 2 diabetes mellitus pharmacological remission with Dapagliflozin plus oral semaglutide